Gábor Gyülvészi, Ph.D
Senior Associate

Gábor Gyülvészi, Ph.D., joined Nextech Invest Ltd. as a senior associate in 2020. Gábor is an immunologist by training with more than 15 years of experience in immunology.

Currently Gabor is a board observer of Exo Therapeutics and Boundless Bio.

Prior to Nextech, Gábor spent seven years as group leader at Roche where he and his team focused on early development of small molecules and antibodies in the cancer immunotherapy field. He directed several collaboration projects with emerging biotech companies and universities. Additionally, Gábor designed the strategy and initiated the project which aimed at identifying novel cancer immunotherapy targets for drug development. Gábor obtained his M.S. degree in molecular biology and genetics from the University of Szeged, Hungary. Later, he received Ph.D from the University of Zurich, and his research focused on autoimmunity and the understanding of T cell activation during multiple sclerosis development. For his Ph.D. research, he received the prestigious Biogen Dompé prize. Upon completion of his Ph.D., he moved to the sunny part of Switzerland where he worked in the Institute for Research in Biomedicine as a postdoctoral fellow, further broadening his immunology expertise.

He is a dedicated father of three and in his remaining free time next to family, he enjoys doing activities such as winter wild-camping in the Alps, long distance cycling, and a 60 km daily bike commute to work.